What is Capmatinib?

Capmatinib is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC), approved by theFDA< The span>approved test detects tumors in which mutations causing mesenchymal epithelial transition (MET) exon 14skip.

Before taking this medicine, tell your doctor if you have:: Other lung problems; lung cancer; or liver disease. Prior to starting this treatment, patients may need to have a negative pregnancy test. Both men and women taking capmatinib should use effective contraception to prevent pregnancy. Capmatinib may harm your unborn baby if the mother or father is using this drug. Continue using birth control for at least 1week after the last dose of birth control, tell your doctor right away if a mother or father becomes pregnant while taking capmatinib. Do not breastfeed while taking this medicine, and at least1weeks after the last dose.

Sometimes it is unsafe to use certain drugs together. Some medicines can affect the blood levels of other medicines you take, which may increase side effects or make the medicine less effective. Other drugs may affect capmatinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all the medicines you currently take and any medicines you start or stop taking. There are generic drugs that are officially on the market in Laos, and each box costs about 3 about 3,000. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.